Polyoxometalates in Biomedicine: Update and Overview

被引:111
作者
Colovic, Mirjana B. [1 ]
Lackovic, Milan [2 ]
Lalatovic, Jovana [3 ]
Mougharbel, Ali S. [4 ]
Kortz, Ulrich [4 ]
Krsti, Danijela Z. [5 ]
机构
[1] Univ Belgrade, Vinca Inst Nucl Sci, Dept Phys Chem, Belgrade 11000, Serbia
[2] Univ Clin Hosp Ctr Dr Dragisa Misovic Dedinje, Belgrade 11000, Serbia
[3] Univ Belgrade, Fac Med, Belgrade 11000, Serbia
[4] Jacobs Univ, Dept Life Sci & Chem, Campus Ring 1, D-28759 Bremen, Germany
[5] Univ Belgrade, Inst Med Chem, Fac Med, Visegradska 26, Belgrade 11000, Serbia
关键词
Polyoxometalates; antiviral; antibacterial; antitumor; normoglycemic activities; biomedicine; DEPENDENT DNA-POLYMERASE; APOPTOTIC CELL-DEATH; IN-VITRO; ANTIBACTERIAL ACTIVITY; RIBOSOMAL-SUBUNIT; METHICILLIN-RESISTANT; PROFOUND ANTICANCER; CRYSTAL-STRUCTURES; ANTITUMOR AGENT; INHIBITION;
D O I
10.2174/0929867326666190827153532
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Polyoxometalates (POMs) are negatively charged metal-oxo clusters of early transition metal ions in high oxidation states (e.g., W-VI, Mo-VI, V-V). POMs are of interest in the fields of catalysis, electronics, magnetic materials and nanotechnology. Moreover, POMs were shown to exhibit biological activities in vitro and in vivo, such as antitumor, antimicrobial, and antidiabetic. Methods: The literature search for this peer-reviewed article was performed using PubMed and Scopus databases with the help of appropriate keywords. Results: This review gives a comprehensive overview of recent studies regarding biological activities of polyoxometalates, and their biomedical applications as promising anti-viral, anti-bacterial, anti-tumor, and anti-diabetic agents. Additionally, their putative mechanisms of action and molecular targets are particularly considered. Conclusion: Although a wide range of biological activities of Polyoxometalates (POMs) has been reported, they are to the best of our knowledge not close to a clinical trial or a final application in the treatment of diabetes or infectious and malignant diseases. Accordingly, further studies should be directed towards determining the mechanism of POM biological actions, which would enable fine-tuning at the molecular level, and consequently efficient action towards biological targets and as low toxicity as possible. Furthermore, biomedical studies should be performed on solution-stable POMs employing physiological conditions and concentrations.
引用
收藏
页码:362 / 379
页数:18
相关论文
共 94 条
[61]   Interaction Study and Reactivity of ZrIV-Substituted Wells-Dawson Polyoxometalate towards Hydrolysis of Peptide Bonds in Surfactant Solutions [J].
Quanten, Thomas ;
Shestakova, Pavletta ;
Van Den Bulck, Dries ;
Kirschhock, Christine ;
Parac-Vogt, Tatjana N. .
CHEMISTRY-A EUROPEAN JOURNAL, 2016, 22 (11) :3775-3784
[62]  
RAYBAUD N, 1972, REV EUR ETUD CL BIOL, V17, P295
[63]   Polyoxometalates as potent and selective inhibitors of alkaline phosphatases with profound anticancer and amoebicidal activities [J].
Raza, Rabia ;
Matin, Abdul ;
Sarwar, Sundas ;
Barsukova-Stuckart, Maria ;
Ibrahim, Masooma ;
Kortz, Ulrich ;
Iqbal, Jamshed .
DALTON TRANSACTIONS, 2012, 41 (47) :14329-14336
[64]   Polyoxometalates in medicine [J].
Rhule, JT ;
Hill, CL ;
Judd, DA .
CHEMICAL REVIEWS, 1998, 98 (01) :327-357
[65]   Polyoxomolybdate Bisphosphonate Heterometallic Complexes: Synthesis, Structure, and Activity on a Breast Cancer Cell Line [J].
Saad, Ali ;
Zhu, Wei ;
Rousseau, Guillaume ;
Mialane, Pierre ;
Marrot, Jerome ;
Haouas, Mohamed ;
Taulelle, Francis ;
Dessapt, Remi ;
Serier-Brault, Helene ;
Riviere, Eric ;
Kubo, Tadahiko ;
Oldfield, Eric ;
Dolbecq, Anne .
CHEMISTRY-A EUROPEAN JOURNAL, 2015, 21 (29) :10537-10547
[66]   Mechanism of polyoxometalate-mediated inactivation of DNA polymerases: An analysis with HIV-1 reverse transcriptase indicates specificity for the DNA-binding cleft [J].
Sarafianos, SG ;
Kortz, U ;
Pope, MT ;
Modak, MJ .
BIOCHEMICAL JOURNAL, 1996, 319 :619-626
[67]   Structure of functionally activated small ribosomal subunit at 3.3 Å resolution [J].
Schluenzen, F ;
Tocilj, A ;
Zarivach, R ;
Harms, J ;
Gluehmann, M ;
Janell, D ;
Bashan, A ;
Bartels, H ;
Agmon, I ;
Franceschi, F ;
Yonath, A .
CELL, 2000, 102 (05) :615-623
[68]   Cytotoxicity and enzyme inhibition studies of polyoxometalates and their chitosan nanoassemblies [J].
Shaha, Hamid Saeed ;
Al-Oweinib, Rami ;
Haiderb, Ali ;
Kortzb, Ulrich ;
Iqbala, Jamshed .
TOXICOLOGY REPORTS, 2014, 1 :341-352
[69]   Degradable Organically-Derivatized Polyoxometalate with Enhanced Activity against Glioblastoma Cell Line [J].
She, Shan ;
Bian, Shengtai ;
Huo, Ruichao ;
Chen, Kun ;
Huang, Zehuan ;
Zhang, Jiangwei ;
Hao, Jian ;
Wei, Yongge .
SCIENTIFIC REPORTS, 2016, 6
[70]   Unprecedented High-Nuclear Transition-Metal-Cluster-Substituted Heteropolyoxoniobates: Synthesis by {V8} Ring Insertion into the POM Matrix and Antitumor Activities [J].
Shen, Jian-Qiang ;
Wu, Qiong ;
Zhang, Ying ;
Zhang, Zhi-Ming ;
Li, Yang-Guang ;
Lu, Ying ;
Wang, En-Bo .
CHEMISTRY-A EUROPEAN JOURNAL, 2014, 20 (10) :2840-2848